Relias Media - Continuing Medical Education Publishing

The trusted source for

healthcare information and

CONTINUING EDUCATION.

  • Sign In
  • Sign Out
  • MyAHC
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • My Subscription
      • Subscribe Now
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    Home » Blogs » Compliance Mentor » Allergan to Pay $3.5 Million for FCA Claim Related to Defective LAP-BANDs

    Compliance Mentor
    Compliance Mentor RSS FeedRSS

    compliance-mentor-static-reliasmedia

    Free Monthly News from the Award Winning Publisher of:

    • Hospital Access Management
    • Hospital Case Management
    • Hospital Employee Health
    • Hospital Infection Control
    • Hospital Peer Review
    • Healthcare Risk Management
    • Case Management Advisor
    • IRB Advisor
    • Medical Ethics Advisor
    • Same-Day Surgery

     

    Allergan to Pay $3.5 Million for FCA Claim Related to Defective LAP-BANDs

    May 24, 2018
    No Comments
    Reprints
    Facebook Twitter Linkedin Share Share
    By Robert B. Vogel, MD, JD

    Robert B. Vogel, MD, JD
    Retinal Ophthalmologist at Piedmont Eye Center, Lynchburg VA;
    Attorney, Overbey Hawkins & Wright, PLLS, Lynchburg, VA;
    Adjunct Professor, Humanities and Bioethics, Liberty University School of Medicine, Lynchburg, VA.

    Allergan Inc. will pay $3.5 million to resolve allegations brought against it under the False Claims Act (FCA). The allegations surround Allergan’s LAP-BAND device, which is used by physicians to assist obese patients with weight reduction.

    The LAP-BAND is an adjustable gastric banding system made of an inflatable silicone band. The band is surgically placed around a patient’s stomach, and its tightness can be adjusted from an external port.

    The federal government alleged that between January 2008 and November 2010, Allergan knowingly sold LAP-BAND devices with defective or flawed access ports.

    According to the allegations, Allergan knew that the ports were prone to leakage, but misrepresented the facts to the public, physicians, and the Food and Drug Administration (FDA). The government also alleged that Allergan offered and provided remuneration to physicians who reported access leaks.

    The complaint further alleged that Allergan knowingly advertised, marketed, and distributed the product for procedures not approved by the FDA.

    The $3.5 million payment will be shared by federal and state Medicaid programs, as well as the whistleblowers, who will receive approximately $600,000.

    The resolution does not involve admission of civil liability by Allergan. At press time, there was no statement regarding these allegations on the company’s website.

     

    Post a comment to this article

    Report Abusive Comment

    www.reliasmedia.com

    Compliance Mentor

    View PDF
    Compliance Mentor - May 2018
    May 1, 2018

    Table Of Contents

    Allergan to Pay $3.5 Million for FCA Claim Related to Defective LAP-BANDs

    CMS Announces ‘Data Driven Patient Care Strategy’

    2019 Medicare Payment and Policy Proposals Are Released

    HHS OIG Says Medicare Paid $3.7 Million in Improper Telehealth Claims

    Shop Now: Search Products

    • Subscription Publications
    • Books & Study Guides
    • Webinars
    • Group & Site
      Licenses
    • State CME/CE
      Requirements

    Webinars And Events

    View All Events
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • My Subscription
      • Subscribe Now
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    • Help
    • Search
    • About Us
    • Sign In
    • Register
    Relias Media - Continuing Medical Education Publishing

    The trusted source for

    healthcare information and

    CONTINUING EDUCATION.

    Customer Service

    customerservice@reliasmedia.com

    U.S. and Canada: 1-800-688-2421 x 2

    International +1-404-262-5476 x 2

    Accounts Receivable

    1-800-688-2421 x 3
    ReliasMedia_AR@reliasmedia.com

    Sales

    1-800-688-2421 x 1

    Mailing Address

    • 1010 Sync St., Suite 100
      Morrisville, NC 27560-5468
      USA

    © 2022 Relias. All rights reserved.

    Do Not Sell My Personal Information  Privacy Policy  Terms of Use  Contact Us  Reprints  Group Sales

    For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com

    Design, CMS, Hosting & Web Development :: ePublishing